Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Breadcrumb Path HyperlinksNative InformationScalp cooling includes carrying a cap that cools the scalp earlier than, throughout and after chemotherapy. Get the most recent...
The time period “practice-changing” is usually used when scientific advances promise to shift conventional therapy paradigms. Discussions popping out of the sixtieth American...
